Hematology/Oncology News

The FDA’s Oncology Center of Excellence has launched a public health initiative designed to improve access to clinical trials of oncology medical products for historically underrepresented populations.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, highlights the important takeaways from International Symposium on Pediatric Neuro-Oncology.

CHICAGO — When Brian E. Persing, MD, attended a state legislative white coat day that ultimately led to prior authorization legislation being passed in Mississippi, one of his colleagues asked him a blunt question.

American Society for Radiation Oncology selected 48 members to receive ASTRO fellow designation.

Health care providers know of the broad potential AI offers for reducing burnout, but which products are actually available for use can be difficult to ascertain, especially considering electronic health record system compatibility.

The FDA granted accelerated approval to afamitresgene autoleucel for certain adults with unresectable or metastatic synovial sarcoma.

The FDA expanded the approval of dostarlimab-gxly for treatment of endometrial cancer.

Career trajectories differed by race and ethnicity among a cohort of “particularly promising” clinician-researchers, with many reporting being likely to leave their current positions in medicine in 2 years, according to survey results.

Many people who experience side effects from cancer treatment wait nearly a month to see a specialist with the necessary expertise.

Chemotherapy-induced changes to the gut microbiome may explain why some patients with cancer experience post-chemotherapy cognitive decline.